Matching these clinical observations, our flow cytometry studies using the MC38 colon cancer model showed that the protein level of GPR84 is abundant in tumor samples, but significantly lower in spleen, bone marrow, and blood (Supplemental 1E). This evidence concerns the gene GPR84 and neoplasm.